ReviewJournal of molecular modeling2026
Carbonic anhydrase under the computational lens: a review of advances, challenges, and future directions.
Review in Journal of molecular modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextCarbonic anhydrases (CAs) are zinc metalloenzymes responsible for the catalysis of the reversible hydration of carbon dioxide and play pivotal roles in many physiological and pathological processes. The complexity of CA isoforms with distinct expression patterns and catalytic characteristics has aroused fierce interest in the development of isoform-selective inhibitors and activators for therapeutic purposes and diagnostics. In this review, a systematic overview of computational and theoretical methods utilized to determine the structure, mechanism, inhibition, and activation of CAs was given. It reviews the evolution and utilization of computational methods in deciphering catalytic and proton transfer mechanisms as well as active-site interactions into atomic resolution and also features recent developments in drug design and screening strategies engineered for CA isoforms, particularly those involved in cancers and Alzheimer's disease. This study can be a reference for multidisciplinary researchers and inspire the future rational design of CA modulators.
methodsThis review summarizes the literature that employed QM and QM/MM by using like B3LYP, BE0-D3BJ, and MD simulations, GROMACS and Desmond packages, and various force fields: OPLS-AA, AMBER14, and CHARMM36. Molecular docking was performed using such as Glide, AutoDock Vina, and GOLD. Machine learning and AI techniques including SVM, LightGBM, SHAP, and neural networks were also reviewed. This review addresses the limitations in these models as well as prospects with newly emerging instruments such as polarizable force fields and real-time DFT as well as explainable AI frameworks, too. Incorporating data-driven insights with physics-based simulations, the next era of work is primed to provide predictive, scalable platforms for rational design of next-generation CA modulators.
Indexed as
Identifiers
42126448What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.